Tad Schweikert: New COO at SCWorx Corp

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

Tad Schweikert has been hired as the new Chief Operating Officer at SCWorx Corporation.  The news was announced today by the company.

Tad Schweikert
Tad Schweikert

Tad Schweikert brings over 28 years of healthcare industry experience. He will be responsible for the strategic growth of the SCWorx customer base and revenue. His team will drive the company’s business development efforts and be responsible for operations for all commercial activities across the company’s existing and potential healthcare provider customers and partners in the United States.

“SCWorx is investing in the talent necessary to develop even more industry-leading data management service offerings so that our healthcare provider customers can operate more efficiently, improve margins and utilize our unique solutions to positively impact business operations,” said Schessel. “Tad is an outstanding senior leader with a proven track record in the healthcare industry. He and his SCWorx team will be instrumental in deepening our commitment to provide healthcare providers with the capabilities and services that make it easier to utilize, and benefit from, SCWorx products and services.”

The company has made significant, ongoing investments in our data management services to respond to the urgent business needs of customers within this evolving marketplace. Recent examples of the company’s progress include the signing of a large industry partner, significant customer wins and the recent launch of a beta version of an advanced web portal application.

“It’s an honor to have the opportunity to join SCWorx, a company I have admired and watched closely,” said Schweikert. “SCWorx has a solid reputation as an innovator in healthcare, is respected for its technology and admired for its people. I am looking forward to leading this dynamic, talented team as we help build the company’s future. It’s going to be an exciting time for customers, partners and employees of SCWorx and it’s a privilege to be part of the team.”

Schweikert was most recently a Senior Principal of Enterprise Solutions at Vizient where he helped grow the business by working with large integrated delivery systems and academic medical centers to improve their margins and align organizational and operational strategies.




Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.